The pharmaceutical industry is absolutely agreeing on the Exclusive Sale Rights Policy
The Pharmaceutical Policy Committee of the Korea Pharmaceutical Manufacturers Association (KPMA), researching and discussing about legislations and policies among pharmaceutical companies,recently held a meeting to conduct a survey for the controversial issue of the Exclusive Sale Rights Policy.
...Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
